Tadalafil causes blood vessels to relax, thus improving circulation and reducing blood pressure in the lungs. It is also used to treat erectile dysfunction, under the brand name Cialis, but in much smaller doses than for PAH.
Tadalafil (ADCIRCA®) is a pill which is usually taken once a day for PAH. It is in a class of drugs called phosphodiesterase-5 Inhibitors (PDE 5 Inhibitors). ADCIRCA® (tadalafil) is manufactured by Eli Lilly and Company, and marketed by Lung Biotechnology PBC and United Therapeutics Corporation.
U.S. Food and Drug Administration Approves New Treatment Combination of Gileadís Letairis® with Tadalafil for Pulmonary Arterial Hypertension (WHO Group 1). The U.S. Food and Drug Administration (FDA) has approved the use of Letairis® (ambrisentan) in combination with tadalafil for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability. Gilead, 10/02/2015. (Also see: Letairis)
United Way of Central New Mexico
United Way of Snohomish County
See ISN News for recent donors, including Pam Hop, Margaret Roof, Winifred Schillberg, Arnold Slotkin, and Juliet Youkhana. Plus donations in honor of Kim Thwaits, and in loving memory of Marta Marx, Jim Miller, and Arlene Marie Petulla.
Click Here to Donate or Shop
or click on the floating green DONATE sclero.org button.
SCLERO.ORG is the world leader for trustworthy research, support, education and awareness for scleroderma and related illnesses, such as pulmonary hypertension. We are a service of the nonprofit International Scleroderma Network (ISN), which is a 501(c)(3) U.S.-based public charitable foundation, established in 2002. Meet Our Team, or Volunteer. Donations may also be mailed to: